C56.2
Malignant neoplasm of left ovary
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the left ovary, classified under ICD-10 code C56.2, refers to ovarian cancer that originates in the left ovary. This form of cancer is characterized by the uncontrolled growth of abnormal cells in the left ovary, which may invade surrounding tissues or spread to other parts of the body. Ovarian cancer can develop silently, often diagnosed at an advanced stage due to subtle symptoms and vague early signs. Recognizing the features and understanding the diagnostic and treatment options are essential for managing this condition effectively.
Causes & Symptoms
Clinical Causes: Genetic mutations, particularly BRCA1 and BRCA2 gene mutations Aging, especially after menopause Obesity and lifestyle factors such as poor diet or lack of exercise Family history of ovarian or breast cancer Reproductive history, including nulliparity or late childbirth Use of certain fertility treatments Hormonal factors that influence ovarian cell growth
Key Symptoms: Persistent bloating or swelling in the abdomen Pelvic or abdominal pain that is unexplained or persistent Feeling full quickly when eating Urinary urgency or frequency Changes in bowel habits, such as constipation Unintended weight loss or gain Fatigue and general malaise
Diagnostic & Treatment
Diagnosis Path: Diagnosing malignant neoplasm of the left ovary involves a combination of medical history assessment, physical examination, and diagnostic tests. Common procedures include pelvic examinations, ultrasound imaging to visualize ovarian abnormalities, and blood tests such as CA-125 to detect tumor markers. In some cases, a CT scan, MRI, or PET scan may be employed to evaluate the extent of disease spread. Definitive diagnosis is made through tissue biopsy, often obtained via surgical procedures or minimally invasive techniques, which allows for histopathological evaluation to determine the cancer type and stage.
Treatment Protocols: Surgical removal of the affected ovary and surrounding tissues, often including hysterectomy and removal of lymph nodes Chemotherapy to target cancer cells and reduce recurrence risk Targeted therapy, which involves drugs that specifically attack cancer cell mechanisms Hormonal therapy in select cases, particularly if hormone receptors are involved Radiation therapy, though less common in ovarian cancer treatment Participation in clinical trials exploring new treatments and therapies
Clinical Advice & FAQs
Billing Guidance
Is C56.2 a billable ICD-10 code?
Yes, C56.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C56.2?
Clinical documentation must specify the nature of Malignant neoplasm of left ovary and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
